December 10, 2021 Comments Off on New patent for Actelion drug UPTRAVI Posted in: Patent Added Annual Drug Patent Expirations for UPTRAVI Uptravi is a drug marketed by Actelion and is included in two NDAs. It is available from one supplier. There are six patents protecting…
The post New patent for Actelion drug UPTRAVI appeared first on DrugPate…
December 10, 2021 Comments Off on New patent for Teva Pharm drug ARMONAIR RESPICLICK Posted in: Patent Added Annual Drug Patent Expirations for ARMONAIR+RESPICLICK Armonair Respiclick is a drug marketed by Teva Pharm and is included in one NDA. It is available from one supplier. There are thirty-one…
The post New patent for Teva Pharm drug ARMONAIR RESPICLICK…
